Blog
938 Articles

Novel Oral Drug Shows Promise
Dr. Barbara Ma provides context for the nine-month data on a clinical trial of the novel drug atebimetinib and standard chemo.

Study Finds Rare Immunotherapy Exceptional Responders
Immunotherapy is not very effective against pancreatic cancer, but Dr. Jordan Winter is taking a closer look at patients who benefitted to see what’s different about them.

PASS-01 Trial Results: Filling the Gaps in Personalized Medicine
The PASS-01 trial results provide data to help clarify how the subtypes of pancreatic cancer respond to the two main treatment protocols.

“Off-the-Shelf” Vaccine Improves Overall and Average Relapse Survival
Dr. Zev Wainberg provides an update on the effectiveness of a vaccine, with results showing it extends the time to relapse in many patients.

Peace of Mind Through Genetic Testing of Pancreatic Cyst Fluid
A patient with pancreatic cysts took a test that looks at genetic markers in the cyst fluid, to determine her risk of developing cancer.

New Pain Control Technology for Locally Advanced Pancreatic Cancer
Dr. Hani Babiker outlines the results of the PANOVA-3 trial, which tested Tumor Treating Fields and chemotherapy for pain control.